$THC News

The Top 5 Analyst Questions From Tenet Healthcare’s Q2 Earnings Call

Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know

3 Reasons Growth Investors Will Love Tenet (THC)

Are You Looking for a Top Momentum Pick? Why Tenet Healthcare (THC) is a Great Choice

Should Value Investors Buy Tenet Healthcare (THC) Stock?

Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue?

Paola M Arbour Takes Money Off The Table, Sells $2.65M In Tenet Healthcare Stock

Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $290

Baird Maintains Neutral on Tenet Healthcare, Raises Price Target to $280

Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $283

Tenet Healthcare's Cost Discipline, Outpatient Growth Drive Strong Q2 Performance, RBC Says

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $308

TD Cowen Maintains Buy on Tenet Healthcare, Raises Price Target to $263

Morgan Stanley Maintains Overweight on Tenet Healthcare, Raises Price Target to $274

RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $283

Tenet raises 2026 outlook after weathering ACA headwinds

Tenet Healthcare Corporation Q2 2026 Earnings Call Summary

Tenet Healthcare (THC) Is Up 19.6% After Strong Q2 Beat, Raised Guidance And Buyback Expansion

Tenet Healthcare's Ambulatory Growth Offsets Emerging Policy Headwinds

Tenet (THC) Q2 2026 Earnings Call Transcript